Genmab Announces Net Sales of DARZALEX® (daratumumab) for Third Quarter of 2017
October 17, 2017 06:52 ET
|
Genmab A/S
Company Announcement
Net sales of DARZALEX in the third quarter of 2017 totaled USD 317 million
Genmab will receive royalties on worldwide net sales from Janssen Biotech,...
Articles of Association for Genmab A/S
October 13, 2017 07:00 ET
|
Genmab A/S
Genmab A/S has published its Articles of Association dated October 5, 2017. The Articles of Association can be found on Genmab’s website: http://ir.genmab.com/releases.cfm
Contact:
Rachel Curtis...
Selskabsvedtægter for Genmab A/S
October 13, 2017 07:00 ET
|
Genmab A/S
Selskabsvedtægter for Genmab A/S dateret den 5. oktober 2017 er blevet offentliggjort. Selskabsvedtægterne er tilgængelige på Genmabs hjemmeside:...
Genmab and Seattle Genetics to Initiate New Study of Novel Antibody-Drug Conjugate Tisotumab Vedotin in Cervical Cancer
October 10, 2017 06:19 ET
|
Genmab A/S
Company Announcement
Phase II study of tisotumab vedotin in patients with advanced cervical cancer
Study provides opportunity for accelerated approval and is expected to begin in the...
Grant of Restricted Stock Units and Warrants to Genmab employees
October 05, 2017 13:27 ET
|
Genmab A/S
Company Announcement
Copenhagen, Denmark; October 5, 2017 – Genmab A/S (Nasdaq Copenhagen: GEN) announced today that at a board meeting the board decided to grant 6,019 restricted stock units and...
Articles of Association for Genmab A/S
September 27, 2017 13:16 ET
|
Genmab A/S
Genmab A/S has published its Articles of Association dated September 26, 2017. The Articles of Association can be found on Genmab’s website: http://ir.genmab.com/releases.cfm
Contact:
Rachel...
Selskabsvedtægter for Genmab A/S
September 27, 2017 13:16 ET
|
Genmab A/S
Selskabsvedtægter for Genmab A/S dateret den 26. september 2017 er blevet offentliggjort. Selskabsvedtægterne er tilgængelige på Genmabs hjemmeside:...
Genmab Announces Approval of DARZALEX® (daratumumab) for Relapsed or Refractory Multiple Myeloma in Japan
September 27, 2017 01:49 ET
|
Genmab A/S
Company Announcement
DARZALEX approved for relapsed or refractory multiple myeloma in Japan
Genmab to receive USD 25 million in milestone payments upon first commercial sale in...
Capital Increase in Genmab as a Result of Employee Warrant Exercise
September 26, 2017 12:57 ET
|
Genmab A/S
Company Announcement
Copenhagen, Denmark; September 26, 2017 – Genmab A/S (Nasdaq Copenhagen: GEN) will increase its share capital by 23,670 shares as a consequence of the exercise of employee...
Genmab to Present at Morgan Stanley 15th Annual Global Healthcare Conference
September 05, 2017 11:37 ET
|
Genmab A/S
Media Release
Copenhagen, Denmark; September 5, 2017 – Genmab A/S (Nasdaq Copenhagen: GEN) announced today that its CEO, Jan van de Winkel, Ph.D., will give a company update at the Morgan Stanley...